Jane Street Group, LLC Inotiv, Inc. Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.66 - $9.87 $112,403 - $668,327	-67,713 Reduced 79.17%	17,814 $29,000
Q1 2024 May 15, 2024	BUY	$3.27 - $11.04 $175,445 - $592,329	53,653 Added 168.33%	85,527 $935,000
Q4 2023 Feb 14, 2024	BUY	$1.69 - $3.86 $34,303 - $78,350	20,298 Added 175.35%	31,874 $116,000
Q3 2023 Nov 14, 2023	SELL	$3.01 - $7.32 $203,599 - $495,132	-67,641 Reduced 85.39%	11,576 $35,000
Q2 2023 Aug 14, 2023	BUY	$4.08 - $7.22 $323,205 - $571,946	79,217 New	79,217 $377,000
Q4 2022 Feb 14, 2023	BUY	$3.77 - $22.1 $199,203 - $1.17 Million	52,839 New	52,839 $261,000
Q2 2022 Aug 16, 2022	BUY	$9.56 - $25.91 $155,130 - $420,441	16,227 New	16,227 $156,000

4.27M

13.1K

21.3K

Ticker NOTV
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 25,594,500
Market Cap $97.8M
Description
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.